Abeona Therapeutics (ABEO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2005 | 12-2004 | 12-2003 | 12-2002 | 12-2001 | |
| Sales | 0 | 0 | 0 | 1,147 | 243 |
| Cost of Goods | N/A | N/A | N/A | 107 | N/A |
| Gross Profit | N/A | N/A | N/A | 1,040 | 243 |
| Operating Expenses | 9,622 | 6,003 | 5,426 | 9,847 | 6,551 |
| Operating Income | -9,622 | -6,003 | -5,426 | -8,700 | -6,308 |
| Interest Expense | 2,100 | 1,385 | 1,281 | 1,278 | 1,170 |
| Other Income | 100 | 226 | 279 | 594 | 1,451 |
| Pre-tax Income | -11,622 | -7,162 | -6,428 | -9,384 | -6,027 |
| Income Tax | -4,067 | N/A | N/A | N/A | N/A |
| Net Income Continuous | -7,555 | -7,162 | -6,428 | -9,384 | -6,027 |
| Net Income Discontinuous | 5,855 | -3,076 | -507 | N/A | N/A |
| Net Income | $-1,700 | $-10,238 | $-6,935 | $-9,384 | $-6,027 |
| EPS Basic Total Ops | -662.50 | -4,225.00 | -3,250.00 | -4,500.00 | -2,937.50 |
| EPS Basic Continuous Ops | -2,925.00 | -2,950.00 | -3,000.00 | -4,475.73 | -2,929.82 |
| EPS Basic Discontinuous Ops | 2,262.50 | -1,275.00 | -250.00 | N/A | N/A |
| EPS Diluted Total Ops | -662.50 | -4,225.00 | -3,250.00 | -4,500.00 | -2,937.50 |
| EPS Diluted Continuous Ops | -2,925.00 | -2,950.00 | -3,000.00 | -4,475.73 | -2,929.82 |
| EPS Diluted Discontinuous Ops | 2,262.50 | -1,275.00 | -250.00 | N/A | N/A |
| EBITDA(a) | $-8,048 | $-4,927 | $-4,528 | $-8,011 | $-5,681 |